These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26859422)

  • 21. THBS1 is induced by TGFB1 in the cancer stroma and promotes invasion of oral squamous cell carcinoma.
    Pal SK; Nguyen CT; Morita KI; Miki Y; Kayamori K; Yamaguchi A; Sakamoto K
    J Oral Pathol Med; 2016 Nov; 45(10):730-739. PubMed ID: 26850833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RANK ligand is a prerequisite for cancer-associated osteolytic lesions.
    Kitazawa S; Kitazawa R
    J Pathol; 2002 Oct; 198(2):228-36. PubMed ID: 12237883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hedgehog and TGFβ signaling converge on Gli2 to control bony invasion and bone destruction in oral squamous cell carcinoma.
    Cannonier SA; Gonzales CB; Ely K; Guelcher SA; Sterling JA
    Oncotarget; 2016 Nov; 7(46):76062-76075. PubMed ID: 27738315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular pathways involved in crosstalk between cancer cells, osteoblasts and osteoclasts in the invasion of bone by oral squamous cell carcinoma.
    Quan J; Zhou C; Johnson NW; Francis G; Dahlstrom JE; Gao J
    Pathology; 2012 Apr; 44(3):221-7. PubMed ID: 22406484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of CXC chemokine ligand 13 in oral squamous cell carcinoma associated osteolysis in athymic mice.
    Pandruvada SN; Yuvaraj S; Liu X; Sundaram K; Shanmugarajan S; Ries WL; Norris JS; London SD; Reddy SV
    Int J Cancer; 2010 May; 126(10):2319-29. PubMed ID: 19816883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer-associated fibroblasts promote bone invasion in oral squamous cell carcinoma.
    Elmusrati AA; Pilborough AE; Khurram SA; Lambert DW
    Br J Cancer; 2017 Sep; 117(6):867-875. PubMed ID: 28742795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The RANKL/RANK system as a therapeutic target for bone invasion by oral squamous cell carcinoma (Review).
    Jimi E; Shin M; Furuta H; Tada Y; Kusukawa J
    Int J Oncol; 2013 Mar; 42(3):803-9. PubMed ID: 23354319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CXCL13 activation of c-Myc induces RANK ligand expression in stromal/preosteoblast cells in the oral squamous cell carcinoma tumor-bone microenvironment.
    Sambandam Y; Sundaram K; Liu A; Kirkwood KL; Ries WL; Reddy SV
    Oncogene; 2013 Jan; 32(1):97-105. PubMed ID: 22330139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secretion of IL-6 and IL-8 from lysophosphatidic acid-stimulated oral squamous cell carcinoma promotes osteoclastogenesis and bone resorption.
    Hwang YS; Lee SK; Park KK; Chung WY
    Oral Oncol; 2012 Jan; 48(1):40-8. PubMed ID: 21925926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual roles of cellular communication network factor 6 (CCN6) in the invasion and metastasis of oral cancer cells to bone via binding to BMP2 and RANKL.
    Hochi H; Kubota S; Takigawa M; Nishida T
    Carcinogenesis; 2023 Dec; 44(8-9):695-707. PubMed ID: 37590989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-1 Generated by Oral Squamous Cell Carcinoma Stimulates Tumor-Induced and RANKL-Induced Osteoclastogenesis: A Possible Mechanism of Bone Resorption Induced by the Infiltration of Oral Squamous Cell Carcinoma.
    Fukawa Y; Kayamori K; Tsuchiya M; Ikeda T
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilization of E-cadherin by monocytes from tumour cells plays key roles in the progression of bone invasion by oral squamous cell carcinoma.
    Quan J; Du Q; Hou Y; Wang Z; Zhang J
    Oncol Rep; 2017 Aug; 38(2):850-858. PubMed ID: 28656299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
    Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
    Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment of a murine model of bone invasion by oral squamous cell carcinoma.
    Nomura T; Shibahara T; Katakura A; Matsubara S; Takano N
    Oral Oncol; 2007 Mar; 43(3):257-62. PubMed ID: 16920384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RANK Ligand Modulation of Autophagy in Oral Squamous Cell Carcinoma Tumor Cells.
    Sambandam Y; Sakamuri S; Balasubramanian S; Haque A
    J Cell Biochem; 2016 Jan; 117(1):118-25. PubMed ID: 26095774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ammonium tetrathiomolybdate enhances the antitumor effects of cetuximab via the suppression of osteoclastogenesis in head and neck squamous carcinoma.
    Morisawa A; Okui T; Shimo T; Ibaragi S; Okusha Y; Ono M; Nguyen TTH; Hassan NMM; Sasaki A
    Int J Oncol; 2018 Mar; 52(3):989-999. PubMed ID: 29328370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CCL28-induced RARβ expression inhibits oral squamous cell carcinoma bone invasion.
    Park J; Zhang X; Lee SK; Song NY; Son SH; Kim KR; Shim JH; Park KK; Chung WY
    J Clin Invest; 2019 Dec; 129(12):5381-5399. PubMed ID: 31487270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical expression of RANKL, RANK, and OPG in human oral squamous cell carcinoma.
    Chuang FH; Hsue SS; Wu CW; Chen YK
    J Oral Pathol Med; 2009 Nov; 38(10):753-8. PubMed ID: 19566744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implications of TP-positive CAFs in the Bone Invasion of Oral Squamous Cell Carcinoma.
    Gao A; Kim DW; Pei M; Kim KY; Park YJ; Nam W; Kim HJ; Kim HS; Cha IH; Zhang X
    Anticancer Res; 2024 Aug; 44(8):3365-3374. PubMed ID: 39060037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of cortical mandibular bone in patients with oral squamous cell carcinoma.
    Rabelo GD; Coutinho-Camillo C; Kowalski LP; Portero-Muzy N; Roux JP; Chavassieux P; Alves FA
    Clin Oral Investig; 2018 Mar; 22(2):783-790. PubMed ID: 28647863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.